Global Allergic Rhinitis Drugs Market 2017-2027

Thursday, July 6, 2017 Drug News
Email Print This Page Comment
Font : A-A+

NEW YORK, July 5, 2017 /PRNewswire/ --

Report DetailsThe global allergic rhinitis drugs market is expected

to grow at a CAGR of 3.2% in the first half of the forecast period. The market is expected to grow at a CAGR of 3.3% from 2016-2027. The market is estimated at $11.9bn in 2016 and $13.9bn in
2021.Read the full report: http://www.reportlinker.com/p04974738/Global-Allergic-Rhinitis-Drugs-Market.htmlHow this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 255-page report you will receive 85 tables and 88 figures – all unavailable elsewhere.The 255-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand new report today you stay better informed and ready to act.Report Scope• Global Allergic Rhinitis Drugs Market forecasts from 2017-2027• Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2027 for the following submarkets:- Intranasal Antihistamines- Intranasal Corticosteroids- Oral Antihistamines- Immunotherapy and Vaccines• How will leading allergic rhinitis drugs perform to 2027 at world level? Our study forecasts individual revenues of these 27 products:- Patanase- Astepro- Astelin- Dymista- Nasonex- Avamys- Veramyst- Flixonase- Rhinocort- Omnaris- Nasacort- Beconase- Qnasl- Zetonna- Allegra- Zyrtec- Claritin- Xyzal- Allelock- Clarinex- Ebastel- Talion- Staloral- Alutard SQ- Grazax- Ragwitek- Generic AzelastineThis report provides individual revenue forecasts to 2027 for these regional and national markets:- US- EU5 - Germany, UK, France, Italy and Spain- China- Japan- India- Russia- Brazil- Rest of the World• Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:- GlaxoSmithKline (GSK)- Merck & Co- Sanofi- Johnson & Johnson- ALK-Abello- UCB- Kyowo Hako Kirin- Stallergenes Greer• This report discusses the trends and development in the allergic rhinitis pipelineRead the full report: http://www.reportlinker.com/p04974738/Global-Allergic-Rhinitis-Drugs-Market.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-allergic-rhinitis-drugs-market-2017-2027-300483636.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook